EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

被引：0
|
作者：
Feng Li
Yongmei Liu
Huijiao Chen
Dianying Liao
Yali Shen
Feng Xu
Jin Wang
机构：
[1] West China Hospital,Radiation Oncology, Tumor Center
[2] Sichuan University,Department of Pathology
[3] West China Hospital,undefined
[4] Sichuan University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词：
Epidermal Growth Factor Receptor; Epidermal Growth Factor Receptor Expression; Epidermal Growth Factor Receptor Gene; Epidermal Growth Factor Receptor Activation; Epidermal Growth Factor Receptor Protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
    Li, Feng
    Liu, Yongmei
    Chen, Huijiao
    Liao, Dianying
    Shen, Yali
    Xu, Feng
    Wang, Jin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [2] Erratum to: EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
    Feng Li
    Yongmei Liu
    Huijiao Chen
    Dianying Liao
    Yali Shen
    Feng Xu
    Jin Wang
    [J]. Journal of Experimental & Clinical Cancer Research, 30
  • [3] EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features (vol 30, pg 27, 2011)
    Li, Feng
    Liu, Yongmei
    Chen, Huijiao
    Liao, Dianying
    Shen, Yali
    Xu, Feng
    Wang, Jin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [4] Targeted COX-2 and EGFR TK inhibition in advanced non-small cell lung cancer.
    Reckamp, K. L.
    Czernin, J.
    Weber, W. A.
    Dubinett, S. M.
    Figlin, R. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [5] Tumor COX-2 expression: a window to pathways and targets in non-small cell lung cancer
    Dubinett, SM
    Dalwadi, H
    Krysan, K
    Dohadwala, M
    Sharma, S
    Mao, JT
    Pold, M
    Gardner, B
    Strieter, R
    Figlin, R
    Riedl, K
    [J]. LUNG CANCER, 2004, 46 : S10 - S11
  • [6] Cox-2 in non-small cell lung cancer: A meta-analysis
    Jiang, Hao
    Wang, Jing
    Zhao, Wei
    [J]. CLINICA CHIMICA ACTA, 2013, 419 : 26 - 32
  • [7] Revisiting the role of COX-2 inhibitor for non-small cell lung cancer
    Yokouchi, Hiroshi
    Kanazawa, Kenya
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 660 - 664
  • [8] HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer
    Brattström, D
    Wester, K
    Bergqvist, M
    Hesselius, P
    Malmström, PU
    Nordgren, H
    Wagenius, G
    Brodin, O
    [J]. ACTA ONCOLOGICA, 2004, 43 (01) : 80 - 86
  • [9] Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility
    Zhang, Tiancheng
    Li, Jing
    Xia, Tian
    Zhang, Nan
    Zhang, Yaozhou
    Zhao, Jian
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 3168 - 3173
  • [10] CORRELATION BETWEEN SCYL1-BP1 AND COX-2 PROTEIN EXPRESSION AND THE CLINICOPATHOLOGICAL PARAMETERS AND PROGNOSIS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Shen, Binghan
    Cai, Zhiming
    Wu, Yanling
    Huang, Gongping
    Ye, Xiaoyi
    [J]. ACTA MEDICA MEDITERRANEA, 2021, 37 (01): : 123 - 128
12345